What are the benefits of laparoscopic hysterectomy compared with open abdominal hysterectomy regarding the risk of postoperative pulmonary embolism and pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laparoscopic Hysterectomy Significantly Reduces Risk of Pulmonary Embolism and Pneumonia Compared to Abdominal Hysterectomy

Laparoscopic hysterectomy should be strongly preferred over abdominal hysterectomy when feasible, as it substantially reduces the risk of venous thromboembolism (including pulmonary embolism) and wound infections, which are key contributors to postoperative pneumonia risk.

Evidence for Reduced Pulmonary Embolism Risk

The most compelling evidence comes from large-scale studies demonstrating clear differences in thromboembolic complications:

  • A nationwide Danish cohort study of 89,931 women found that laparoscopic hysterectomy reduced VTE risk by approximately 50% compared to abdominal hysterectomy (adjusted HR = 0.51; 95% CI, 0.28-0.92) 1. The crude 30-day VTE incidence was 0.13% for laparoscopic versus 0.24% for abdominal hysterectomy.

  • A large U.S. cohort of 94,940 patients confirmed these findings, showing VTE incidence of 0.3% for laparoscopic hysterectomy versus 0.7% for abdominal hysterectomy (p <.001) 2. This represents more than a 50% reduction in thromboembolic risk.

  • In endometrial cancer patients undergoing minimally invasive surgery, laparoscopic hysterectomy was associated with a 68% reduction in VTE risk compared to open surgery (0.7% vs. 2.2%, p<.001), even when most patients received thromboprophylaxis 3.

The mechanism behind this benefit relates to earlier mobilization, shorter hospital stays, and reduced surgical trauma with laparoscopic approaches 4, 5.

Evidence for Reduced Pneumonia and Infection Risk

Current ACR guidelines (2024) explicitly state that laparoscopic hysterectomy is associated with lower rates of wound infection compared to abdominal hysterectomy 6. While the guidelines focus on wound infections rather than pneumonia specifically, these are interconnected:

  • Wound infections increase systemic inflammatory burden and immobility
  • Abdominal hysterectomy requires larger incisions causing more pain, limiting deep breathing and cough effectiveness
  • The longer hospital stays with abdominal hysterectomy (consistently documented across studies) increase nosocomial infection exposure

A Cleveland Clinic study of 3,226 hysterectomies found overall pulmonary complication rates were very low (0.3%) with no statistical difference between approaches 7. However, this likely reflects the rarity of pneumonia as an outcome rather than equivalence, as the study was underpowered for this specific comparison.

Guideline Recommendations

The 2024 ACR Appropriateness Criteria for Management of Uterine Fibroids provides the clearest directive: "If hysterectomy is indicated, the least invasive route for hysterectomy should be performed" 6. The guidelines specifically note that:

  • Abdominal hysterectomy is associated with longer hospital stay, recovery time, greater pain, and higher risk of infection
  • Laparoscopic hysterectomy provides faster return to normal activities, shorter hospital stays, and lower rates of wound infection 6

The 2023 NCCN Uterine Neoplasms Guidelines reinforce this, stating that minimally invasive techniques result in "lower rate of surgical site infection, transfusion, venous thromboembolism, decreased hospital stay, and lower cost of care" 4.

Clinical Algorithm for Route Selection

  1. First-line choice: Laparoscopic or vaginal hysterectomy for all eligible patients
  2. Reserve abdominal hysterectomy for:
    • Very large uteri that cannot be safely removed laparoscopically
    • Multiple large fibroids precluding laparoscopic approach
    • Elderly patients with significant comorbidities limiting pneumoperitoneum tolerance
    • Suspected extrauterine malignancy requiring extensive staging 4

Important Caveats

Note the cervical cancer exception: The 2019 NCCN Cervical Cancer Guidelines document that minimally invasive radical hysterectomy for early-stage cervical cancer showed inferior oncologic outcomes (lower disease-free and overall survival) compared to open surgery in the LACC trial 8. This is specific to radical hysterectomy for cancer and does not apply to benign hysterectomy.

For benign indications, the evidence consistently favors laparoscopic approaches for reducing both VTE/pulmonary embolism risk and infection-related complications including pneumonia 2, 1, 4.

Thromboprophylaxis Considerations

Regardless of surgical approach, postoperative heparin thromboprophylaxis significantly reduces VTE risk (adjusted HR = 0.63; 95% CI, 0.42-0.96) and should be considered, especially when risk factors are present 1. Higher ASA classification independently predicts increased VTE risk 2.

References

Guideline

uterine neoplasms, version 1.2023, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2023

Guideline

uterine neoplasms, version 1.2018, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2018

Guideline

acr appropriateness criteria® management of uterine fibroids: 2023 update.

Journal of the American College of Radiology, 2024

Research

Common postoperative pulmonary complications after hysterectomy for benign indications.

American journal of obstetrics and gynecology, 2013

Guideline

cervical cancer, version 3.2019, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.